KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $473,000 | +392.7% | 66,700 | +324.8% | 0.01% | +400.0% |
| Q1 2017 | $96,000 | -92.9% | 15,700 | -93.2% | 0.00% | -97.1% |
| Q4 2016 | $1,345,000 | +287.6% | 229,600 | +208.2% | 0.03% | +100.0% |
| Q1 2016 | $347,000 | +46.4% | 74,500 | +10.4% | 0.02% | -5.6% |
| Q3 2015 | $237,000 | -82.3% | 67,500 | -14.3% | 0.02% | -71.9% |
| Q1 2014 | $1,342,000 | +633.3% | 78,800 | +333.0% | 0.06% | +300.0% |
| Q3 2013 | $183,000 | +123.2% | 18,200 | +64.0% | 0.02% | +14.3% |
| Q2 2013 | $82,000 | – | 11,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,312,006 | $22,357,000 | 15.70% |
| VHCP Management, LLC | 1,000,273 | $17,045,000 | 8.86% |
| HARVEY CAPITAL MANAGEMENT INC | 915,800 | $15,605,000 | 6.22% |
| Baupost Group | 6,310,850 | $107,537,000 | 2.60% |
| SECTORAL ASSET MANAGEMENT INC | 3,537,590 | $60,281,000 | 2.48% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 587,504 | $10,011,000 | 2.31% |
| Knoll Capital Management, LLC | 200,000 | $3,408,000 | 1.76% |
| Camber Capital Management LP | 1,250,000 | $21,300,000 | 1.67% |
| NORTHPOINTE CAPITAL LLC | 877,875 | $14,958,000 | 1.52% |
| DAFNA Capital Management LLC | 100,000 | $1,704,000 | 1.46% |